Page results
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
File results
-
FOI/2022/0286 - Fat-shaming complaints
-
FOI/2022/0287 - Device related delays in delivery of medication/ enteral feeding
-
FOI/2022/0288 - Patient deaths awaiting discharge as inpatient
-
FOI/2022/0293 - Patients treated with Ponvory, Tysabri, Vumerity, Zeposia
-
FOI/2022/0294 - IT systems validation document management system
-
FOI/2022/0295 - Procurement Organisation Structure chart
-
FOI/2022/0300 - EPRR Coordination of emergency/disaster management activities
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0305 - Ethnic minority categories used for Gypsy, Roma, Traveller groups